Nilotinib cause moyamoya disease in the treatment of chronic myelogenous leukemia during chronic phase: A case report

Asian J Surg. 2023 Sep;46(9):4001-4002. doi: 10.1016/j.asjsur.2023.04.020. Epub 2023 May 1.
No abstract available

Keywords: Chronic myelogenous leukemia; Moyamoya disease; Nilotinib.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Chronic Disease
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
  • Moyamoya Disease*
  • Pyrimidines / therapeutic use
  • Treatment Outcome

Substances

  • Pyrimidines
  • Antineoplastic Agents

Supplementary concepts

  • Moyamoya disease 1